CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE

被引：0
|
作者：
Frascaro, F. [1 ]
Pavasini, R. [1 ]
Marchini, F. [1 ]
Bianchi, N. [1 ]
Zanarelli, L. [1 ]
Sanguettoli, F. [1 ]
Meossi, S. [1 ]
Guardigli, G. [1 ]
机构：
[1] Azienda Osped Univ St Anna, Ferrara, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P422
引用
收藏
页码：D211 / D211
页数：1
相关论文
共 50 条
  • [31] A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors
    Lessomo, Fabrice Yves Ndjana
    Mandizadza, Oscar Onayi
    Mukuka, Chishimba
    Wang, Zhi-Quan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [32] Cardiotoxicity of immune checkpoint inhibitors: A meta-analysis of randomized clinical trials
    Agostinetto, E.
    Eiger, D.
    Lambertini, M.
    Ceppi, M.
    Bruzzone, M.
    Ponde, N. F.
    Plummer, C.
    Awada, A. H.
    Piccart, M.
    de Azambuja, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [33] Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab
    Gomez, Pablo Rodriguez de Vera
    Tous Romero, Maria del Castillo
    Portillo, Cristobal Morales
    Olmedo, Isabel Serrano
    Brocca, Maria Asuncion Martinez
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (05): : 363 - 365
  • [34] Clinical manifestation and management of immune checkpoint inhibitor-associated cardiotoxicity
    Guo, Xiaoxiao
    Wang, Hanping
    Zhou, Jiaxin
    Li, Yue
    Duan, Lian
    Si, Xiaoyan
    Zhang, Li
    Fang, Ligang
    Zhang, Li
    THORACIC CANCER, 2020, 11 (02) : 475 - 480
  • [35] Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
    Chitturi, Kalyan R.
    Araujo-Gutierrez, Raquel
    McLean, Edward T.
    Xu, Jiaqiong
    Bhimaraj, Arvind
    Guha, Ashrith
    Hussain, Imad
    Trachtenberg, Barry H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S50 - S50
  • [36] Advances in immune checkpoint inhibitors induced-cardiotoxicity
    Li, Xiang
    Peng, Wenying
    Wu, Jiao
    Yeung, Sai-Ching Jim
    Yang, Runxiang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] MYOCARDITIS IN LUNG CANCER PATIENT TREATED WITH DURVALUMAB: CARDIOTOXICITY DUE TO IMMUNE CHECKPOINT INHIBITORS? A CHALLENGING CLINICAL CASE
    Leopizzi, T.
    Fioretti, A.
    Longo, V.
    Stanzione, R.
    Aprile, P. D.
    Sassara, M.
    Caldarola, P.
    Oliva, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C82 - C82
  • [38] Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients
    Li Yiqun
    Wang Yanfeng
    Li Ning
    Liang Xinjun
    Zhang Shu
    Fan Qingxia
    Yin Xianli
    Zhuang Zhixiang
    Liu Yunpeng
    Zhang Jingdong
    Kou Xiaoge
    Zhong Haijun
    Xu Binghe
    Huang Jing
    中华医学杂志(英文版), 2022, (08) : 988 - 990
  • [39] Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients
    Li, Yiqun
    Wang, Yanfeng
    Li, Ning
    Liang, Xinjun
    Zhang, Shu
    Fan, Qingxia
    Yin, Xianli
    Zhuang, Zhixiang
    Liu, Yunpeng
    Zhang, Jingdong
    Kou, Xiaoge
    Zhong, Haijun
    Xu, Binghe
    Huang, Jing
    CHINESE MEDICAL JOURNAL, 2022, 135 (08) : 988 - 990
  • [40] Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature
    Chauhan, A.
    Burkeen, G.
    Houranieh, J.
    Arnold, S.
    Anthony, L.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 2034 - +
12345